Streetbeat News

Products Services

NVDA

Nvidia's CEO Jensen Huang announced significant advancements in the company's GPU technology, which are now being used in data centers for AI model development. This news is likely to positively impact Nvidia's stock.

Portfolio Pulse from

January 19, 2025 | 11:45 pm

TTGT

Omdia projects that industrial display panel revenue will reach USD 2.4 billion by 2025, driven by e-cigarettes, game consoles, and two-wheeled vehicles. Shipments are expected to grow by 10.9% YoY in 2024, with smart home and office applications leading the market.

Portfolio Pulse from

January 19, 2025 | 11:15 pm

MSTR

Jay Pestrichelli highlights Tidal's ETFs, focusing on BIGY, an option income ETF. He emphasizes the importance of choice for investors in engaging with options.

Portfolio Pulse from

January 19, 2025 | 8:30 pm

MSFT

Microsoft (NASDAQ: MSFT) has started 2025 strongly, with its stock generally trading positively. AI predicts the stock price for February 1, 2025.

Portfolio Pulse from

January 19, 2025 | 8:30 pm

HIMS

Hims & Hers Health is considered undervalued by the market, with analysts focusing too much on GLP-1 concerns and potential FDA restrictions. Despite this, the company projects a 90% YoY growth for Q4 and is expanding its non-GLP-1 business. Innovative product launches, like meal replacement bars, emphasize its focus on personalized health services.

Portfolio Pulse from

January 19, 2025 | 8:30 pm

AMD

AMD is poised to benefit significantly from the increasing demand for inference compute driven by reasoning models like OpenAI's 'o1'. The company's superior memory bandwidth, latency capabilities, and modular chiplet design make it a strong investment in the AI landscape.

Portfolio Pulse from

January 19, 2025 | 8:00 pm

META

Meta has launched a new video editing app named Edits following the removal of ByteDance's CapCut from app stores due to the TikTok ban.

Portfolio Pulse from

January 19, 2025 | 7:45 pm

QMCO

The article discusses the potential of quantum computing stocks as a significant investment opportunity, highlighting the transformative impact of quantum computing technology.

Portfolio Pulse from

January 19, 2025 | 7:15 pm

MRK

MRNA

Moderna, despite recent setbacks, is seen as an acquisition target due to its mRNA-based Personal Cancer Vaccines, which are crucial for Merck to extend KEYTRUDA's patent protection. Merck faces significant revenue loss post-2028, making Moderna's market cap attractive.

Portfolio Pulse from

January 19, 2025 | 7:00 pm

UCO

The ProShares Ultra Bloomberg Crude Oil ETF (UCO) is not recommended for purchase at current prices due to an expected surplus in the oil market and increased global supply, which may lead to a decrease in oil prices. The ETF is designed for short-term movements, not for conservative investors.

Portfolio Pulse from

January 19, 2025 | 7:00 pm